Erin Roesch, MD

Articles

Dynamic treatment for early-stage triple-negative breast cancer

November 02, 2021

Standard chemotherapy has historically been the mainstay of treatment for patients with diagnoses of early-stage TNBC, but there remains an unmet need to identify novel therapies that improve outcomes and, equally important, to discern which patients may benefit from a given treatment.